These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Skin hypersensitivity reactions to transdermal therapeutic systems--still an important clinical problem. Jenerowicz D; Polańska A; Olek-Hrab K; Silny W Ginekol Pol; 2012 Jan; 83(1):46-50. PubMed ID: 22384639 [TBL] [Abstract][Full Text] [Related]
6. Hercon technology for transdermal delivery of drugs. Shah KR; Ng S; Zeoli L; Haight V; Matz S; Kydonieus AF J Biomater Appl; 1986 Oct; 1(2):239-73. PubMed ID: 3146634 [TBL] [Abstract][Full Text] [Related]
7. Transdermal drug delivery and cutaneous metabolism. Guy RH; Hadgraft J; Bucks DA Xenobiotica; 1987 Mar; 17(3):325-43. PubMed ID: 3107225 [TBL] [Abstract][Full Text] [Related]
8. Structure-activity relationship of chemical penetration enhancers in transdermal drug delivery. Kanikkannan N; Kandimalla K; Lamba SS; Singh M Curr Med Chem; 2000 Jun; 7(6):593-608. PubMed ID: 10702628 [TBL] [Abstract][Full Text] [Related]
9. Preparation and characterization of microemulsion formulations of nicotinic acid and its prodrugs for transdermal delivery. Tashtoush BM; Bennamani AN; Al-Taani BM Pharm Dev Technol; 2013; 18(4):834-43. PubMed ID: 23030413 [TBL] [Abstract][Full Text] [Related]
10. Transdermal delivery of contraceptives. Friend DR Crit Rev Ther Drug Carrier Syst; 1990; 7(2):149-86. PubMed ID: 2272099 [TBL] [Abstract][Full Text] [Related]
11. Transdermal drug delivery: a review of pharmaceutics, pharmacokinetics, and pharmacodynamics. Moore L; Chien YW Crit Rev Ther Drug Carrier Syst; 1988; 4(4):285-349. PubMed ID: 3133121 [TBL] [Abstract][Full Text] [Related]
12. Enhanced transdermal permeability of estradiol using combination of PLGA nanoparticles system and iontophoresis. Tomoda K; Watanabe A; Suzuki K; Inagi T; Terada H; Makino K Colloids Surf B Biointerfaces; 2012 Sep; 97():84-9. PubMed ID: 22609586 [TBL] [Abstract][Full Text] [Related]
13. Your CE topic (No. 111). Clinical application of transdermal drug delivery systems (Part II). Lackner TE J Pract Nurs; 1990 Mar; 40(1):42-50. PubMed ID: 2109799 [No Abstract] [Full Text] [Related]
14. [Transdermal therapeutic methods]. Aiache JM Ann Cardiol Angeiol (Paris); 1997; 46(7):441-9. PubMed ID: 9452779 [TBL] [Abstract][Full Text] [Related]
15. [Therapeutic systems and drug delivery. 3. Transdermal therapeutic systems]. Davila D; Karleusa-Simanović A; Davila T Lijec Vjesn; 1990; 112(7-8):235-43. PubMed ID: 2292898 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of nitroglycerin and clonidine delivered by the transdermal route. Shaw JE Am Heart J; 1984 Jul; 108(1):217-23. PubMed ID: 6428208 [TBL] [Abstract][Full Text] [Related]
17. Systemic delivery of antihypertensive drugs via skin. Güngör S; Ozsoy Y Ther Deliv; 2012 Sep; 3(9):1101-16. PubMed ID: 23035594 [TBL] [Abstract][Full Text] [Related]
18. [Transdermal therapeutic systems]. Primorac M; Odri S; Stupar M; Vuleta G Srp Arh Celok Lek; 1985 Oct; 113(10):893-900. PubMed ID: 3938572 [No Abstract] [Full Text] [Related]
19. Electrically assisted skin delivery of liposomal estradiol; phospholipid as damage retardant. Essa EA; Bonner MC; Barry BW J Control Release; 2004 Mar; 95(3):535-46. PubMed ID: 15023464 [TBL] [Abstract][Full Text] [Related]
20. Adverse dermatologic reactions to transdermal drug delivery systems. Hogan DJ; Maibach HI J Am Acad Dermatol; 1990 May; 22(5 Pt 1):811-4. PubMed ID: 2112162 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]